[F-18]FDG and [C-11]Acetate PET/CT study for refractory diseases
Not Applicable
- Conditions
- hematologic malignancies and refractory or recurrent malignancies
- Registration Number
- JPRN-UMIN000023101
- Lead Sponsor
- Tokyo Medical and Dental University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
i. serum glucose level greater than 200mg/dl ii. pregnancy or possible iii. patients can't demonstrate informed consent iv. early gastric cancer in which [F-18]FDG PET/CT isn't applicable for covered health insurance
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method